Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Run-Down

The cancer labs of Elizabeth Blackburn, Chad Mirkin, and Elaine Mardis and Rick Wilson get shout-outs in three US News & World Report articles. Blackburn is looking to exploit cancer cells' use of telomerase to engineer a way to kill the cells; she is also intrigued by lifestyle influences, such as exercise and nutrition, on telomerase levels. Mirkin's lab has developed nanoparticles that change color when they come in contact with certain proteins, such as ones associated with heart attack or prostate cancer. Finally, Mardis and Wilson are planning to sequence 150 cancer patients, focusing on people with leukemia, breast cancer, and lung cancers with the hope of finding what makes the tumors different so that tailored treatments can then be developed.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.